Compare Immunovant Inc. Common Stock (IMVT) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs XP Inc. Class A Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while XP Inc. Class A Common Stock trades at $30.27 (market cap $14.99B). The key difference: XP Inc. Class A Common Stock is far larger — about 2.3× Immunovant Inc. Common Stock's market cap, and XP Inc. Class A Common Stock pays a 0.68% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and XP Inc. Class A Common Stock for 0 Days on average.
| IMVT | XP | |
|---|---|---|
Market Cap | $6.62B | $14.99B |
Volume | 1,131,364 | 14,273,752 |
Sector | Health | Financials |
52-Week High | $44.96 | $30.21 |
52-Week Low | $17.03 | $14.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $24.70B |
Dividend Yield | — | 0.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
